The antibody-blind-spot lift is the most actionable line in this release. The MSA inductive bias breaks down in domains where multi-species co-evolution data is sparse, and antibodies are the canonical example. A pure-scale MSA-blind model topping the antibody benchmark changes which therapeutic programs become viable on internal compute, not which papers get cited.
The antibody-blind-spot lift is the most actionable line in this release. The MSA inductive bias breaks down in domains where multi-species co-evolution data is sparse, and antibodies are the canonical example. A pure-scale MSA-blind model topping the antibody benchmark changes which therapeutic programs become viable on internal compute, not which papers get cited.